| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/26/2023 | 20.38% | Truist Securities | $101 → $97 | Maintains | Buy |
| 08/07/2023 | 27.82% | UBS | $88 → $103 | Maintains | Buy |
| 07/27/2023 | 25.34% | Truist Securities | $93 → $101 | Maintains | Buy |
| 05/19/2023 | -4.44% | Credit Suisse | $91 → $77 | Downgrades | Outperform → Neutral |
| 05/02/2023 | -13.13% | TD Cowen | $75 → $70 | Maintains | Outperform |
| 04/27/2023 | 7.97% | Baird | $91 → $87 | Maintains | Outperform |
| 01/23/2023 | 11.69% | Truist Securities | $84 → $90 | Maintains | Buy |
| 12/13/2022 | 15.41% | Credit Suisse | → $93 | Initiates Coverage On | → Outperform |
| 11/22/2022 | 9.21% | Jefferies | $87 → $88 | Downgrades | Buy → Hold |
| 10/10/2022 | 20.38% | JP Morgan | $86 → $97 | Maintains | Overweight |
| 08/23/2022 | 15.41% | UBS | $88 → $93 | Maintains | Buy |
| 07/28/2022 | 0.52% | RBC Capital | $76 → $81 | Maintains | Sector Perform |
| 07/28/2022 | 0.52% | Baird | $76 → $81 | Maintains | Outperform |
| 07/14/2022 | — | JP Morgan | Upgrades | Neutral → Overweight | |
| 07/01/2022 | -9.41% | Cowen & Co. | $80 → $73 | Maintains | Market Perform |
| 06/10/2022 | -6.92% | Morgan Stanley | $79 → $75 | Maintains | Equal-Weight |
| 04/28/2022 | 11.69% | Citigroup | $100 → $90 | Maintains | Buy |
| 04/25/2022 | -1.96% | Morgan Stanley | $84 → $79 | Maintains | Equal-Weight |
| 01/27/2022 | 4.24% | Morgan Stanley | $83 → $84 | Maintains | Equal-Weight |
| 01/10/2022 | 14.17% | Goldman Sachs | $82 → $92 | Maintains | Buy |
| 01/07/2022 | -0.72% | Cowen & Co. | → $80 | Downgrades | Outperform → Market Perform |
| 12/15/2021 | 3% | Morgan Stanley | $80 → $83 | Maintains | Equal-Weight |
| 10/28/2021 | -0.72% | Morgan Stanley | $75 → $80 | Maintains | Equal-Weight |
| 09/27/2021 | -0.72% | Goldman Sachs | $75 → $80 | Maintains | Buy |
| 09/22/2021 | 9.21% | Jefferies | $84 → $88 | Maintains | Buy |
| 07/29/2021 | -5.68% | RBC Capital | $73 → $76 | Maintains | Sector Perform |
| 07/29/2021 | -6.92% | Morgan Stanley | $70 → $75 | Maintains | Equal-Weight |
| 04/29/2021 | -0.72% | Citigroup | $70 → $80 | Maintains | Buy |
| 04/29/2021 | -13.13% | Morgan Stanley | $66 → $70 | Maintains | Equal-Weight |
| 03/08/2021 | -18.09% | Morgan Stanley | $65.5 → $66 | Maintains | Equal-Weight |
| 03/05/2021 | -18.71% | Morgan Stanley | $131 → $65.5 | Maintains | Equal-Weight |
| 12/14/2020 | 62.57% | Morgan Stanley | $115 → $131 | Maintains | Equal-Weight |
| 10/22/2020 | 42.72% | Morgan Stanley | $110 → $115 | Maintains | Equal-Weight |
| 10/20/2020 | 57.61% | Baird | → $127 | Initiates Coverage On | → Outperform |
| 09/16/2020 | 65.05% | UBS | → $133 | Initiates Coverage On | → Buy |
| 08/24/2020 | 36.51% | Morgan Stanley | → $110 | Downgrades | Overweight → Equal-Weight |
| 07/23/2020 | 31.55% | Morgan Stanley | $101 → $106 | Maintains | Overweight |
| 06/23/2020 | 17.9% | Stifel | $80 → $95 | Maintains | Hold |
| 06/16/2020 | 25.34% | Morgan Stanley | $86 → $101 | Maintains | Overweight |
| 04/23/2020 | 11.69% | JP Morgan | $96 → $90 | Maintains | Neutral |
| 04/23/2020 | 17.9% | Wells Fargo | $90 → $95 | Maintains | Overweight |
| 04/02/2020 | 17.9% | B of A Securities | $120 → $95 | Reiterates | → Buy |
| 03/18/2020 | 6.73% | Morgan Stanley | $107 → $86 | Maintains | Overweight |
| 03/10/2020 | 32.79% | Morgan Stanley | $112 → $107 | Maintains | Overweight |
| 01/21/2020 | — | Cross Research | Downgrades | Hold → Sell | |
| 12/18/2019 | 38.99% | Morgan Stanley | $104 → $112 | Maintains | Overweight |
| 12/17/2019 | 36.51% | RBC Capital | → $110 | Initiates Coverage On | → Sector Perform |
| 12/16/2019 | 55.13% | Jefferies | → $125 | Initiates Coverage On | → Buy |
| 10/24/2019 | 38.99% | Wells Fargo | $109 → $112 | Maintains | Outperform |
| 10/22/2019 | 29.06% | JP Morgan | → $104 | Initiates Coverage On | → Neutral |
| 07/25/2019 | 29.06% | Morgan Stanley | $108 → $104 | Maintains | Overweight |
| 06/17/2019 | — | Longbow Research | Downgrades | Buy → Neutral | |
| 06/10/2019 | 34.03% | Morgan Stanley | $110 → $108 | Maintains | Overweight |
| 06/06/2019 | 26.58% | Evercore ISI Group | → $102 | Initiates Coverage On | → Outperform |
| 04/02/2019 | 38.99% | SunTrust Robinson Humphrey | $89 → $112 | Upgrades | Hold → Buy |
| 03/05/2019 | 36.51% | Morgan Stanley | $100 → $110 | Maintains | Overweight |
What is the target price for Amphenol (APH)?
The latest price target for Amphenol (NYSE: APH) was reported by Truist Securities on October 26, 2023. The analyst firm set a price target for $97.00 expecting APH to rise to within 12 months (a possible 20.38% upside). 9 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Amphenol (APH)?
The latest analyst rating for Amphenol (NYSE: APH) was provided by Truist Securities, and Amphenol maintained their buy rating.
When is the next analyst rating going to be posted or updated for Amphenol (APH)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Amphenol, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Amphenol was filed on October 26, 2023 so you should expect the next rating to be made available sometime around October 26, 2024.
Is the Analyst Rating Amphenol (APH) correct?
While ratings are subjective and will change, the latest Amphenol (APH) rating was a maintained with a price target of $101.00 to $97.00. The current price Amphenol (APH) is trading at is $80.58, which is out of the analyst's predicted range.